BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27424149)

  • 1. Design and validation of a consistent and reproducible manufacture process for the production of clinical-grade bone marrow-derived multipotent mesenchymal stromal cells.
    Codinach M; Blanco M; Ortega I; Lloret M; Reales L; Coca MI; Torrents S; Doral M; Oliver-Vila I; Requena-Montero M; Vives J; Garcia-López J
    Cytotherapy; 2016 Sep; 18(9):1197-208. PubMed ID: 27424149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion.
    Grisendi G; Annerén C; Cafarelli L; Sternieri R; Veronesi E; Cervo GL; Luminari S; Maur M; Frassoldati A; Palazzi G; Otsuru S; Bambi F; Paolucci P; Pierfranco C; Horwitz E; Dominici M
    Cytotherapy; 2010 Jul; 12(4):466-77. PubMed ID: 20353309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparability exercise of critical quality attributes of clinical-grade human mesenchymal stromal cells from the Wharton's jelly: single-use stirred tank bioreactors versus planar culture systems.
    López-Fernández A; Codinach M; Coca MI; Prat-Vidal C; Castaño J; Torrents S; Aran G; Rodríguez L; Querol S; Vives J
    Cytotherapy; 2024 May; 26(5):418-426. PubMed ID: 37715777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality Control Assays for Clinical-Grade Human Mesenchymal Stromal Cells: Methods for ATMP Release.
    Radrizzani M; Soncin S; Lo Cicero V; Andriolo G; Bolis S; Turchetto L
    Methods Mol Biol; 2016; 1416():313-37. PubMed ID: 27236681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A xenogeneic-free bioreactor system for the clinical-scale expansion of human mesenchymal stem/stromal cells.
    Dos Santos F; Campbell A; Fernandes-Platzgummer A; Andrade PZ; Gimble JM; Wen Y; Boucher S; Vemuri MC; da Silva CL; Cabral JM
    Biotechnol Bioeng; 2014 Jun; 111(6):1116-27. PubMed ID: 24420557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data.
    Rojewski MT; Lotfi R; Gjerde C; Mustafa K; Veronesi E; Ahmed AB; Wiesneth M; Körper S; Sensebé L; Layrolle P; Hellem S; Schrezenmeier H
    Cytotherapy; 2019 Apr; 21(4):468-482. PubMed ID: 30926359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow mesenchymal stem cell aspirates from alternative sources: is the knee as good as the iliac crest?
    Narbona-Carceles J; Vaquero J; Suárez-Sancho S; Forriol F; Fernández-Santos ME
    Injury; 2014 Oct; 45 Suppl 4():S42-7. PubMed ID: 25384474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton's Jelly.
    Grau-Vorster M; Rodríguez L; Del Mazo-Barbara A; Mirabel C; Blanco M; Codinach M; Gómez SG; Querol S; García-López J; Vives J
    Cells; 2019 May; 8(5):. PubMed ID: 31117301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of IL-17F and IL-33 correlate with HLA-DR activation in clinical-grade human bone marrow-derived multipotent mesenchymal stromal cell expansion cultures.
    Grau-Vorster M; Rodríguez L; Torrents-Zapata S; Vivas D; Codinach M; Blanco M; Oliver-Vila I; García-López J; Vives J
    Cytotherapy; 2019 Jan; 21(1):32-40. PubMed ID: 30447901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of in vitro hematopoietic supportive capability of human mesenchymal stem cells derived from bone marrow and umbilical cord].
    Liu M; Yang SG; Liu PX; DU WT; Gu DS; Lu SH; Xing W; Han ZC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1294-300. PubMed ID: 19840470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts.
    Brune JC; Tormin A; Johansson MC; Rissler P; Brosjö O; Löfvenberg R; von Steyern FV; Mertens F; Rydholm A; Scheding S
    Int J Cancer; 2011 Jul; 129(2):319-30. PubMed ID: 20878957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at U.S. academic centers.
    Phinney DG; Galipeau J;
    Cytotherapy; 2019 Jul; 21(7):782-792. PubMed ID: 31182333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Good manufacturing practice-compliant animal-free expansion of human bone marrow derived mesenchymal stroma cells in a closed hollow-fiber-based bioreactor.
    Nold P; Brendel C; Neubauer A; Bein G; Hackstein H
    Biochem Biophys Res Commun; 2013 Jan; 430(1):325-30. PubMed ID: 23146633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality Control Assays for Clinical-Grade Human Mesenchymal Stromal Cells: Validation Strategy.
    Radrizzani M; Soncin S; Bolis S; Lo Cicero V; Andriolo G; Turchetto L
    Methods Mol Biol; 2016; 1416():339-56. PubMed ID: 27236682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More mesenchymal stem cells enriched from bone marrow aspirates by culturing bone marrow particles and mononuclear cells separately.
    Xing W; Liu PX; Liu M; Yang SG; Zhao QJ; Li JP; Lu SH; Ren HY; Huang Y; Wu H; Liu B; Zhang L; Han ZC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1552-9. PubMed ID: 21176369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-platform quality control assay to quantify multipotential stromal cells in bone marrow aspirates prior to bulk manufacture or direct therapeutic use.
    Cuthbert R; Boxall SA; Tan HB; Giannoudis PV; McGonagle D; Jones E
    Cytotherapy; 2012 Apr; 14(4):431-40. PubMed ID: 22268519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of mesenchymal stromal cells from human degenerated nucleus pulposus: comparison with bone marrow mesenchymal stromal cells from the same subjects.
    Blanco JF; Graciani IF; Sanchez-Guijo FM; Muntión S; Hernandez-Campo P; Santamaria C; Carrancio S; Barbado MV; Cruz G; Gutierrez-Cosío S; Herrero C; San Miguel JF; Briñon JG; del Cañizo MC
    Spine (Phila Pa 1976); 2010 Dec; 35(26):2259-65. PubMed ID: 20622750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of GMP-compliant culture media for in vitro expansion of human bone marrow mesenchymal stromal cells.
    Wuchter P; Vetter M; Saffrich R; Diehlmann A; Bieback K; Ho AD; Horn P
    Exp Hematol; 2016 Jun; 44(6):508-18. PubMed ID: 26911671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
    Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
    Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of methods for cultivating limbal mesenchymal stromal cells.
    Bray LJ; Heazlewood CF; Atkinson K; Hutmacher DW; Harkin DG
    Cytotherapy; 2012 Sep; 14(8):936-47. PubMed ID: 22587591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.